Icosavax Raises $100m To Take RSV, COVID-19 Vaccines Into The Clinic

Platform Enables Vaccines Based On Non-Naturally Occurring VLPs

 
• By Mandy Jackson
Vaccine vial dose
Icosavax's first vaccines aim to prevent COVID-19 and pneumonia • Source: Shutterstock

More from Financing

More from Business